FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STROMMEN JACK B.

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/19/2017 

3. Issuer Name and Ticker or Trading Symbol

BIOLARGO, INC. [BLGO]

(Last)        (First)        (Middle)

7108 31ST AVENUE NORTH

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

MINNEAPOLIS, MN 55427       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrants (Right to Buy)   8/26/2015   (1) 6/1/2026   Common Stock   1400000   $0.4000   D    
Common Stock Warrants (Right to Buy)   10/8/2015   6/1/2026   Common Stock   1857143   $0.4500   D    
Convertible Promissory Notes due 2018   8/26/2015   (2) 6/1/2018   Common Stock   1400000   $0.2500   D    
Convertible Promissory Notes due 2018   10/8/2015   6/1/2018   Common Stock   1857143   $0.3500   D    

Explanation of Responses:
(1)  The Common Stock Warrants described are comprised of two separate Warrant grants, made on August 26, 2015 and September 9, 2015, respectively. Each such Common Stock Warrant includes identical terms and was immediately exercisable upon grant.
(2)  The Convertible Promissory Notes described are comprised of two Convertible Promissory Notes, issued on August 26, 2015 and September 9, 2015, respectively. Each such Convertible Promissory Note includes identical terms and was immediately convertible upon issuance.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
STROMMEN JACK B.
7108 31ST AVENUE NORTH
MINNEAPOLIS, MN 55427
X



Signatures
/s/ Jack B. Strommen 6/28/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more BioLargo (QB) Charts.
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more BioLargo (QB) Charts.